Men with certain cardiovascular risk factors may be at increased risk of peripheral artery disease
2012-10-24
(Press-News.org) CHICAGO – Among nearly 45,000 men who were followed up for more than two decades, those with the risk factors of smoking, hypertension, high cholesterol, and type 2 diabetes had an associated greater risk of developing PAD, according to a study in the October 24/31 issue of JAMA.
"Peripheral artery disease (PAD) is a distinct atherosclerotic syndrome marked by stenosis or occlusion [blockage] of the arteries, particularly of the lower extremities. PAD affects 8 to 10 million individuals in the United States, and is associated with reduced functional capacity and increased risk for cardiovascular morbidity and mortality. Despite its widespread prevalence and negative associations with quality of life, morbidity, and mortality, PAD remains underdiagnosed and undertreated," according to background information in the article. Preventable or treatable risk factors for PAD are generally thought to be similar to other forms of cardiovascular disease, however their respective associations with risk of PAD and the extent to which they are jointly associated with the incidence of PAD are not well established.
Michel M. Joosten, Ph.D., of Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, and colleagues conducted a study to estimate the individual and cumulative associations of the 4 conventional cardiovascular risk factors of smoking, hypertension, hypercholesterolemia, and type 2 diabetes with the risk of PAD among men. The study included 44,985 men in the United States without a history of cardiovascular disease at the beginning of the study in 1986; participants in the Health Professionals Follow-up Study were followed up for 25 years until January 2011. The presence of risk factors was updated biennially during follow-up.
During a median (midpoint) follow-up of 24.2 years, there were 537 cases of incident PAD. The researchers found that each risk factor was significantly and independently associated with a higher risk of PAD after adjustment for the other 3 risk factors and confounders. Regardless of duration category, all men with a risk factor had higher risks of developing PAD compared with men without risk factors. Each additional risk factor approximately doubled the risk for PAD. Men who did not have any of the 4 risk factors had a 77 percent lower risk for developing PAD compared with all other men in the group. In 96 percent of PAD cases, at least 1 of the 4 risk factors was present at the time of PAD diagnosis.
Risk of PAD tended to increase with duration of both type 2 diabetes and hypercholesterolemia. Among men with a positive history of hypertension, risk of PAD was higher among men who reported use of 1 antihypertensive drug or 2 or more antihypertensive drugs compared with men with hypertension who did not report current use of antihypertensive drugs. Cumulative intensity of smoking demonstrated a graded relationship with risk.
"In conclusion, in this well-characterized cohort of U.S. men followed up for longer than 2 decades, smoking, hypertension, hypercholesterolemia, and type 2 diabetes each demonstrated strong, graded, and independent associations with risk of clinically significant PAD," the authors write.
###
(JAMA. 2012;308[16]:1660-1667. Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: This work was supported by grants from the National Institutes of Health. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.
To contact Michel M. Joosten, Ph.D., call Kelly Lawman at 617-667-7305 or email klawman@bidmc.harvard.edu.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-10-24
CHICAGO – In an examination of the characteristics of studies that yield large treatment effects from medical interventions, these studies were more likely to be smaller in size, often with limited evidence, and when additional trials were performed, the effect sizes became typically much smaller, according to a study in the October 24/31 issue of JAMA.
"Most effective interventions in health care confer modest, incremental benefits," according to background information in the article. "Large effects are important to document reliably because in a relative scale they ...
2012-10-24
CHICAGO –Among patients without acute respiratory distress syndrome, protective mechanical ventilation with use of lower tidal volumes (the volume of air inhaled and exhaled during each breath) was associated with better outcomes including less lung injury, lower mortality, fewer pulmonary infections and a shorter hospital length of stay, according to a meta-analysis of previous studies, reported in the October 24/31 issue of JAMA.
"Mechanical ventilation is a life-saving strategy in patients with acute respiratory failure. However, unequivocal evidence suggests that ...
2012-10-24
Lives could be saved by removing age restrictions on rotavirus vaccination
A study published in this week's PLOS Medicine, which suggests that the additional children's lives saved by removing the age restrictions for rotavirus vaccination in low- and middle-income countries would be much greater than any extra deaths from vaccine-associated complications (namely, intussusception-a form of bowel obstruction), has informed policy regarding the age restrictions for this vaccine.
Hundreds of thousands of infants world-wide have been vaccinated against rotavirus (which ...
2012-10-24
A new study reported in this week's PLOS Medicine reports findings from a study carried out in four African countries by Carla Makhlouf Obermeyer and colleagues on approaches towards expanding testing and counselling for HIV. Provider-initiated HIV testing has the potential to expand access to treatment and prevention services, but there have been concerns as to whether consent practices, client confidentiality, and the referral to care will be acceptable under provider-initiated testing modes.
The study, conducted in Burkina Faso, Kenya, Malawi and Uganda, found that ...
2012-10-24
When regulatory systems for medical products in low-and middle-income countries work, people live but when such systems fail, people die, according to experts from the US Food and Drug Administration (FDA) writing in this week's PLOS Medicine.
Charles Preston, Mary Lou Valdez, and Katherine Bond from the Office of International Programs at the FDA, argue that few global initiatives focus on strengthening the medical product regulatory systems in low-and middle-income countries but that globalization and the scaling up of medicines and vaccines to these countries are highlighting ...
2012-10-24
STANFORD, Calif. — Use of colonoscopy for colorectal cancer screening could explain a significant decrease in the cancer's incidence over the past decade, according to a new study from researchers at the Stanford University School of Medicine. Although colonoscopy is now the most common colorectal cancer screening method, there has been conflicting evidence as to its effectiveness compared with sigmoidoscopy, a method that examines only a portion of the colon.
The team scrutinized data collected from more than 2 million patients over the past 20 years, and found that ...
2012-10-24
SALT LAKE CITY, Oct. 24, 2012 – Computer simulations provide new mathematical support for the "grandmother hypothesis" – a famous theory that humans evolved longer adult lifespans than apes because grandmothers helped feed their grandchildren.
"Grandmothering was the initial step toward making us who we are," says Kristen Hawkes, a distinguished professor of anthropology at the University of Utah and senior author of the new study published Oct. 24 by the British journal Proceedings of the Royal Society B.
The simulations indicate that with only a little bit of grandmothering ...
2012-10-24
BOSTON – Although placebos have played a critical role in medicine and clinical research for more than 70 years, it has been a mystery why these inactive treatments help to alleviate symptoms in some patients – and not others. Now researchers have for the first time identified genetic differences between placebo responders and non-responders, providing an important new clue to what has come to be known as "the placebo effect."
Led by investigators at Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School (HMS), the new findings demonstrate that genetic ...
2012-10-24
The laws that govern how intricate surface patterns, such as those found in the cauliflower, develop over time have been described, for the first time, by a group of European researchers.
In a study published today, 24 October, in the Institute of Physics and German Physical Society's New Journal of Physics, researchers have provided a mathematical formula to describe the processes that dictate how cauliflower-like patterns – a type of fractal pattern – form and develop.
The term fractal defines a pattern that, when you take a small part of it, looks similar, although ...
2012-10-24
It has long been known that breast density, or mammographic density, is a strong risk factor for breast cancer, and that estrogen and progestin hormone therapy increases dense breast tissue. Now, a study published in BioMed Central's open access journal Breast Cancer Research has identified several gene variants in hormone metabolism and growth factor pathways that may be associated with breast density and, hence, breast cancer risk.
Mammographic density relates to the fact that x-rays permeate different types of breast tissue in different ways, leading to white areas ...
LAST 30 PRESS RELEASES:
[Press-News.org] Men with certain cardiovascular risk factors may be at increased risk of peripheral artery disease
